Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease
Open accessAbstract
Background & aims The intestinal microbiome might affect the development and severity of nonalcoholic fatty liver disease (NAFLD). We analyzed microbiomes of children with and without NAFLD.Methods We performed a prospective, observational, cross-sectional study of 87 children (age range, 8-17 years) with biopsy-proven NAFLD and 37 children with obesity without NAFLD (controls). Fecal samples were collected and microbiome composition and functions were assessed using 16S ribosomal RNA amplicon sequencing and metagenomic shotgun sequencing. Microbial taxa were identified using zero-inflated negative binomial modeling. Genes contributing to bacterial pathways were identified using gene set enrichment analysis.Results Fecal microbiomes of children with NAFLD had lower α-diversity than those of control children (3.32 vs 3.52, P = .016). Fecal microbiomes from children with nonalcoholic steatohepatitis (NASH) had the lowest α-diversity (control, 3.52; NAFLD, 3.36; borderline NASH, 3.37; NASH, 2.97; P = .001). High abundance of Prevotella copri was associated with more severe fibrosis (P = .036). Genes for lipopolysaccharide biosynthesis were enriched in microbiomes from children with NASH (P < .001). Classification and regression tree model with level of alanine aminotransferase and relative abundance of the lipopolysaccharide pathway gene encoding 3-deoxy-d-manno-octulosonate 8-phosphate-phosphatase identified patients with NASH with an area under the receiver operating characteristic curve value of 0.92. Genes involved in flagellar assembly were enriched in the fecal microbiomes of patients with moderate to severe fibrosis (P < .001). Classification and regression tree models based on level of alanine aminotransferase and abundance of genes encoding flagellar biosynthesis protein had good accuracy for identifying case children with moderate to severe fibrosis (area under the receiver operating characteristic curve, 0.87).Conclusions In an analysis of fecal microbiomes of children with NAFLD, we associated NAFLD and NASH with intestinal dysbiosis. NAFLD and its severity were associated with greater abundance of genes encoding inflammatory bacterial products. Alterations to the intestinal microbiome might contribute to the pathogenesis of NAFLD and be used as markers of disease or severity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MASH fibrosis is linked to a unique gut microbiome.
“MASH fibrosis is linked to a unique gut microbiome (193-197), and specific microbiome signatures can distinguish human MASH from MASLD (4, 198, 199).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [195]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,013 · see citing works
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,587 · see citing works
Non‐parametric multivariate analyses of changes in community structure
Clarke, K. R. (1993) · Australian Journal of Ecology · doi:10.1111/j.1442-9993.1993.tb00438.x · Cited by 14,196 · see citing works
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · see citing works
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726 · see citing works
Self-citationDesign and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works
Self-citationDiet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · see citing works
SPECIES ASSEMBLAGES AND INDICATOR SPECIES:THE NEED FOR A FLEXIBLE ASYMMETRICAL APPROACH
Dufrêne, M., & Legendre, P. (1997) · Ecological Monographs · doi:10.1890/0012-9615(1997)067[0345:saaist]2.0.co;2 · Cited by 8,346 · see citing works
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815 · see citing works
Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. (2007) · Nature · doi:10.1038/nature06244 · Cited by 6,091 · see citing works
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · see citing works
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · see citing works
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · see citing works
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662 · see citing works
Species Assemblages and Indicator Species: The Need for a Flexible Asymmetrical Approach
Dufrêne, M., & Legendre, P. (1997) · Ecological Monographs · doi:10.2307/2963459 · Cited by 4,154 · see citing works
Microbiome Datasets Are Compositional: And This Is Not Optional
Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V., & Egozcue, J. J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02224 · Cited by 3,044 · see citing works
KEGG for representation and analysis of molecular networks involving diseases and drugs
Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322 · see citing works
Diet–microbiota interactions as moderators of human metabolism
Sonnenburg, J. L., & Bäckhed, F. (2016) · Nature · doi:10.1038/nature18846 · Cited by 2,257 · see citing works
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E. G., Abramson, S. B., et al. (2013) · eLife · doi:10.7554/elife.01202 · Cited by 2,047 · see citing works
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942 · see citing works
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · see citing works
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · see citing works
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C. R., & Behling, C. A. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1212 · Cited by 1,477 · see citing works
Self-citationMetabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome
Abubucker, S., Segata, N., Goll, J. B., Schubert, A. M., Izard, J., Cantarel, B. L., Rodriguez-Mueller, B., Zucker, J., Thiagarajan, M., Henrissat, B., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002358 · Cited by 1,050 · see citing works
Self-citationDumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042 · see citing works
Stress and stability: applying the Anna Karenina principle to animal microbiomes
Zaneveld, J. R., McMinds, R., & Vega Thurber, R. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.121 · Cited by 977 · see citing works
Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.026 · Cited by 960 · see citing works
Vaure, C., & Liu, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00316 · Cited by 842 · see citing works
Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics
Holmes, I. H., Harris, K. J., & Quince, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030126 · Cited by 834 · see citing works
Obesity and the human microbiome
Ley, R. E. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328333d751 · Cited by 760 · see citing works
Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #
Schwimmer, J. B., Behling, C. A., Newbury, R., Deutsch, R., Nievergelt, C. M., Schork, N. J., & Lavine, J. E. (2005) · Hepatology · doi:10.1002/hep.20842 · Cited by 749 · see citing works
Self-citationDel Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696 · see citing works
Rivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693 · see citing works
Maeda, Y., Kurakawa, T., Umemoto, E., Motooka, D., Ito, Y., Gotoh, K., Hirota, K., Matsushita, M., Furuta, Y., Narazaki, M., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39783 · Cited by 686 · see citing works
Väremo, L., Nielsen, J., & Nookaew, I. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt111 · Cited by 683 · see citing works
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
Shen, F., Zheng, R.-D., Sun, X.-Q., Ding, W.-J., Wang, X.-Y., & Fan, J.-G. (2017) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/s1499-3872(17)60019-5 · Cited by 563 · see citing works
In vivo characterization of the liver fat 1H MR spectrum
Hamilton, G., Yokoo, T., Bydder, M., Cruite, I., Schroeder, M. E., Sirlin, C. B., & Middleton, M. S. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1622 · Cited by 520 · see citing works
Self-citationThe role of the gut microbiota in nonalcoholic fatty liver disease
Abu-Shanab, A., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.172 · Cited by 457 · see citing works
Ridout, M. S., Hinde, J., & Demétrio, C. G. B. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00219.x · Cited by 426 · see citing works
labdsv: Ordination and Multivariate Analysis for Ecology
Roberts, D. W. (2005) · doi:10.32614/cran.package.labdsv · Cited by 392 · see citing works
Poggi, M., Bastelica, D., Gual, P., Iglesias, M. A., Grémeaux, T., Knauf, C., Peiretti, F., Verdier, M., Juhan-Vague, I., Tanti, J., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0654-8 · Cited by 351 · see citing works
A Gut Microbiome Signature for Cirrhosis Due to Nonalcoholic Fatty Liver Disease
Caussy, C., Tripathi, A., Humphrey, G., Bassirian, S., Singh, S., Faulkner, C., Bettencourt, R., Rizo, E., Richards, L., Xu, Z. Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09455-9 · Cited by 338 · see citing works
Self-citationMicrobiota-liver axis in hepatic disease
Chassaing, B., Etienne‐Mesmin, L., & Gewirtz, A. T. (2013) · Hepatology · doi:10.1002/hep.26494 · Cited by 329 · see citing works
TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system
Miao, E. A., Andersen‐Nissen, E., Warren, S. E., & Aderem, A. A. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0078-z · Cited by 296 · see citing works
Csák, T., Velayudham, A., Hritz, I., Petrášek, J., Levin, I., Lippai, D., Catalano, D. E., Mandrekar, P., Dolganiuc, A., Kurt‐Jones, E. A., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00163.2009 · Cited by 229 · see citing works
Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
Newton, K. P., Hou, J., Crimmins, N. A., Lavine, J. E., Barlow, S. E., Xanthakos, S. A., Africa, J. A., Behling, C. A., Donithan, M., Clark, J. M., et al. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2016.1971 · Cited by 224 · see citing works
Self-citationInflammasomes: far beyond inflammation
Henao‐Mejia, J., Elinav, E., Strowig, T., & Flavell, R. A. (2012) · Nature Immunology · doi:10.1038/ni.2257 · Cited by 185 · see citing works
Gut Microbiota, Low-grade Inflammation, and Metabolic Syndrome
Chassaing, B., & Gewirtz, A. T. (2013) · Toxicologic Pathology · doi:10.1177/0192623313508481 · Cited by 174 · see citing works
Optimal phased-array combination for spectroscopy
Bydder, M., Hamilton, G., Yokoo, T., & Sirlin, C. B. (2008) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2008.01.050 · Cited by 92 · see citing works
Self-citationCousin, F., Lynch, S. M., Harris, H. M. B., McCann, A., Lynch, D. B., Neville, B. A., Irisawa, T., Okada, S., Endo, A., & O’Toole, P. W. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03594-14 · Cited by 61 · see citing works
Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
Chackelevicius, C. M., Gambaro, S. E., Tiribelli, C., & Rosso, N. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9096 · Cited by 58 · see citing works
Hofer, U. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3180 · Cited by 53 · see citing works
Characterization of flagellins isolated from a highly motile strain of Lactobacillus agilis
Kajikawa, A., Midorikawa, E., Masuda, K., Kondo, K., Irisawa, T., Igimi, S., & Okada, S. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0667-x · Cited by 36 · see citing works
Hofer, U. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3192 · Cited by 27 · see citing works
Mahmud, S., Lou, W. W., & Johnston, N. W. (2010) · BMC Medical Research Methodology · doi:10.1186/1471-2288-10-55 · Cited by 16 · see citing works
Vijay–Kumar, M., & Gewirtz, A. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.064 · Cited by 12 · see citing works
Hedgehog Spikes Pancreas Regeneration
Cano, D. A., & Hebrok, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.063 · Cited by 12 · see citing works
Sequencing the gut metagenome as a noninvasive diagnosis for advanced nonalcoholic steatohepatitis
Zhu, L., Baker, R. D., Zhu, R., & Baker, S. S. (2017) · Hepatology · doi:10.1002/hep.29387 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works
Targher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 848 · see citing works
The role of the gut microbiome and its metabolites in metabolic diseases
Wu, J., Wang, K., Wang, X., Pang, Y., & Jiang, C. (2020) · Protein & Cell · doi:10.1007/s13238-020-00814-7 · Cited by 584 · see citing works
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448 · see citing works
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Chen, J., & Vitetta, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155214 · Cited by 357 · see citing works
Nonalcoholic Fatty Liver Disease
Zhao, Y.-C., Zhao, G., Chen, Z., She, Z., Cai, J., & Li, H. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13419 · Cited by 244 · see citing works
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 226 · see citing works
Lujan, P. V., Esmel, E. V., & Sacanella, E. (2021) · Nutrients · doi:10.3390/nu13051442 · Cited by 212 · see citing works
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Sookoian, S. C., Salatino, A., Castaño, G. O., Landa, M. S., Fijalkowky, C., Garaycoechea, M. E., & Pirola, C. J. (2020) · Gut · doi:10.1136/gutjnl-2019-318811 · Cited by 204 · see citing works
An Introduction to Next Generation Sequencing Bioinformatic Analysis in Gut Microbiome Studies
Gao, B., Chi, L., Zhu, Y., Shi, X., Tu, P., Li, B. J., Yin, J., Gao, N., Shen, W., & Schnabl, B. (2021) · Biomolecules · doi:10.3390/biom11040530 · Cited by 165 · see citing works
The curious case of Prevotella copri
Abdelsalam, N. A., Hegazy, S. M., & Aziz, R. K. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2249152 · Cited by 163 · see citing works
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works
Witjes, J. J., Smits, L. P., Pekmez, C. T., Prodan, A., Meijnikman, A. S., Troelstra, M., Bouter, K. E. C., Herrema, H., Levin, E., Holleboom, A. G., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1601 · Cited by 156 · see citing works
Risk assessment with gut microbiome and metabolite markers in NAFLD development
Leung, H., Long, X., Ni, Y., Qian, L., Nychas, E., Siliceo, S. L., Pohl, D., Hanhineva, K., Liu, Y., Xu, A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk0855 · Cited by 152 · see citing works
Plaza‐Díaz, J., Solis‐Urra, P., Rodríguez‐Rodríguez, F., Arancibia, J. E. O., Navarro-Oliveros, M., Abadía‐Molina, F., & Álvarez‐Mercado, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218351 · Cited by 147 · see citing works
Xu, L., Zhang, Y., Li, X., Li, C., Hu, H., Hu, J., Liu, M., Yang, Q. Z., Gu, P., Li, J., et al. (2025) · iMeta · doi:10.1002/imt2.270 · Cited by 138 · see citing works
Non-alcoholic fatty liver disease and childhood obesity
Shaunak, M., Byrne, C. D., Davis, N. L., Afolabi, P. R., Faust, S. N., & Davies, J. H. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-318063 · Cited by 128 · see citing works
Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
Bauer, K. C., Littlejohn, P. T., Ayala, V., Creus-Cuadros, A., & Finlay, B. B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.058 · Cited by 124 · see citing works
Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges
Goldner, D. L., & Lavine, J. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.048 · Cited by 128 · see citing works
Self-citationKhan, A., Ding, Z., Ishaq, M. H., Bacha, A. S., KHAN, I. A., Hanif, A., Li, W., & Guo, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56214 · Cited by 126 · see citing works
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Jiao, T., Ma, Y., Guo, X., Ye, Y., & Xie, C. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00880-z · Cited by 122 · see citing works
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
Park, J. W., Kim, S. E., Lee, N. Y., Kim, J. H., Jung, J.-H., Jang, M.-K., Park, S.-H., Lee, M.-S., Kim, D.-J., Kim, H.-S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010426 · Cited by 109 · see citing works
Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease
Yu, E. L., & Schwimmer, J. B. (2021) · Clinical Liver Disease · doi:10.1002/cld.1027 · Cited by 107 · see citing works
Self-citationGut Microbiome and Its Impact on Obesity and Obesity-Related Disorders
Sankararaman, S., Noriega, K. J., Velayuthan, S., Sferra, T. J., & Martindale, R. G. (2022) · Current Gastroenterology Reports · doi:10.1007/s11894-022-00859-0 · Cited by 108 · see citing works
Tokuhara, D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.700058 · Cited by 104 · see citing works
Lau, H. C.-H., Zhang, X., & Yu, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01089-1 · Cited by 112 · see citing works
Houttu, V., Csader, S., Nieuwdorp, M., Holleboom, A. G., & Schwab, U. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.716783 · Cited by 95 · see citing works
Kanda, T., Goto, T., Hirotsu, Y., Masuzaki, R., Moriyama, M., & Omata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041525 · Cited by 95 · see citing works
Tsai, M., Liu, Y.-Y., Lin, C., Wang, C., Wu, Y., Yong, C., Chen, K., Chuah, S., Yao, C., Huang, P., et al. (2020) · Nutrients · doi:10.3390/nu12030820 · Cited by 92 · see citing works
Zhu, X., Cai, J., Wang, Y., Liu, X., Chen, X., Wang, H., Wu, Z., Bao, W., Fan, H., & Wu, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316733 · Cited by 91 · see citing works
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Jennison, E., & Byrne, C. D. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0129 · Cited by 89 · see citing works
Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100018 · Cited by 94 · see citing works
Watanabe, T., Tsuchiya, A., Takeuchi, S., Nojiri, S., Yoshida, T., Ogawa, M., Itoh, M., Takamura, M., Suganami, T., Ogawa, Y., et al. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.03.012 · Cited by 84 · see citing works
Epidemiology and Rb1 gene of retinoblastoma.
Yun, J., Li, Y., Xu, C.-T., & Pan, B.-R. (2011) · PubMed Central · doi:10.3980/j.issn.2222-3959.2011.01.24 · Cited by 84 · see citing works
Kravetz, A. M., Testerman, T., Galuppo, B., Graf, J., Pierpont, B. M., Siebel, S., Feinn, R., & Santoro, N. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa382 · Cited by 83 · see citing works
Lin, Y., Lin, H.-F., Wu, C.-C., Chen, C., & Ni, Y. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01909-0 · Cited by 83 · see citing works
Xanthakos, S. A., Ibrahim, S. H., Adams, K. H., Kohli, R., Sathya, P., Sundaram, S. S., Vos, M. B., Dhawan, A., Caprio, S., Behling, C. A., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001368 · Cited by 86 · see citing works
Self-citationFianchi, F., Liguori, A., Gasbarrini, A., Grieco, A., & Miele, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126485 · Cited by 75 · see citing works
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 74 · see citing works
Su, X. B., Chen, S., Liu, J., Feng, Y., Han, E., Hao, X., Liao, M., Cai, J., Zhang, S., Niu, J., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13646 · Cited by 74 · see citing works
Dong, T. S., Katzka, W. R., Lagishetty, V., Luu, K., Hauer, M., Pisegna, J. R., & Jacobs, J. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-59535-w · Cited by 72 · see citing works
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 74 · see citing works
Pan, X., Kaminga, A. C., Liu, A., Wen, S. W., Luo, M., & Luo, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.683743 · Cited by 68 · see citing works
Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health
Traversi, D., Pulliero, A., Izzotti, A., Franchitti, E., Iacoviello, L., Gianfagna, F., Gialluisi, A., Izzi, B., Agodi, A., Barchitta, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020135 · Cited by 73 · see citing works
Integrated Multi‐Cohort Analysis of the Parkinson's Disease Gut Metagenome
Boktor, J. C., Sharon, G., Metman, L. V., Hall, D. A., Engen, P. A., Zreloff, Z. J., Hakim, D., Bostick, J. W., Ousey, J. A., Lange, D., et al. (2023) · Movement Disorders · doi:10.1002/mds.29300 · Cited by 68 · see citing works
The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression
Chen, D., Le, T. H., Shahidipour, H., Read, S. A., & Ahlenstiel, G. (2019) · Cells · doi:10.3390/cells8111324 · Cited by 67 · see citing works
Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
Zhang, X., Chen, L., Yang, J., Zhao, S.-S., Jin, S., Ao, N., Yang, J., Liu, H., & Du, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1117644 · Cited by 66 · see citing works
Kwan, S., Jiao, J., Joon, A. Y., Wei, P., Petty, L. E., Below, J. E., Daniel, C. R., Wu, X., Zhang, J., Jenq, R. R., et al. (2021) · Hepatology · doi:10.1002/hep.32197 · Cited by 64 · see citing works
Zheng, C., Wang, L., Zou, T., Lian, S., Luo, J., Lu, Y., Hao, H., Xu, Y., Xiang, Y., Zhang, X., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2023.12.024 · Cited by 63 · see citing works
Zhao, T., Zhan, L., Zhou, W., Chen, W., Luo, J., Zhang, L., Weng, Z., Zhao, C., & Liu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.647529 · Cited by 60 · see citing works
Maevskaya, M. V., Kotovskaya, Y. V., Ivashkin, V. T., Ткачева, О. Н., Troshina, E. A., Shestakova, M. V., Breder, V. V., Geyvandova, N. I., Doshchitsin, V. L., Dudinskaya, Е. N., et al. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.02.201363 · Cited by 65 · see citing works
Li, F., Zhang, T., He, Y., Gu, W., Yang, X., Zhao, R., & Yu, J. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112232 · Cited by 60 · see citing works
Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma
Voigt, A. Y., Emiola, A., Johnson, J. S., Fleming, E. S., Nguyen, H. T., Zhou, W. L., Tsai, K. Y., Fink, C., & Oh, J. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.03.017 · Cited by 61 · see citing works
Self-citationZhou, J., Zhang, Q., Zhao, Y., Zou, Y. F., Chen, M., Zhou, S., & Wang, Z. (2022) · Scientific Reports · doi:10.1038/s41598-022-25140-2 · Cited by 60 · see citing works
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
Mandala, A., Janssen, R., Palle, S. K., Short, K., & Friedman, J. (2020) · Nutrients · doi:10.3390/nu12103166 · Cited by 51 · see citing works
Zhang, L., El-Shabrawi, M. H. F., Baur, L. A., Byrne, C. D., Targher, G., Kehar, M., Porta, G., Lee, W. S., Lefere, S., Turan, S., et al. (2024) · Med · doi:10.1016/j.medj.2024.03.017 · Cited by 59 · see citing works
Yang, M., Yin, Y., Wang, F., Zhang, H., Ma, X., Yin, Y., Tan, B., & Chen, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.719967 · Cited by 56 · see citing works
Ali, R., Quinn, G. M., Umarova, R., Haddad, J. A., Zhang, G. Y., Townsend, E. C., Scheuing, L., Hill, K., Gewirtz, M. A., Rampertaap, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01273-y · Cited by 52 · see citing works
Gut Microbiome and Organ Fibrosis
Costa, C. F. F. A., Sampaio‐Maia, B., Araújo, R., Nascimento, D. S., Ferreira‐Gomes, J., Pestana, M., Azevedo, M. J., & Alencastre, I. S. (2022) · Nutrients · doi:10.3390/nu14020352 · Cited by 51 · see citing works
Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension
Kountouras, J., Papaefthymiou, A., Pοlyzos, S. A., Deretzi, G., Vardaka, E., Soteriades, E. S., Tzitiridou‐Chatzopoulou, M., Gkolfakis, P., Karafyllidou, K., & Doulberis, M. (2021) · Microorganisms · doi:10.3390/microorganisms9112351 · Cited by 49 · see citing works
The influence of host genetics on liver microbiome composition in patients with NAFLD
Pirola, C. J., Salatino, A., Quintanilla, M. F., Castaño, G. O., Garaycoechea, M. E., & Sookoian, S. C. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103858 · Cited by 49 · see citing works
Depletion of Gut Microbiota Inhibits Hepatic Lipid Accumulation in High-Fat Diet-Fed Mice
Han, H. L., Wang, M., Zhong, R., Yi, B., Schroyen, M., & Zhang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169350 · Cited by 49 · see citing works
Statistical analysis of microbiome data: The challenge of sparsity
Pan, A. (2021) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2021.05.005 · Cited by 49 · see citing works
Self-citationHe, L., Yao, D.-H., Wang, L., Zhang, L., & Bai, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.761836 · Cited by 48 · see citing works
Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer
Francescangeli, F., Angelis, M. L. D., & Zeuner, A. (2019) · Nutrients · doi:10.3390/nu11122936 · Cited by 49 · see citing works
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Zhou, J., Tripathi, M., Sinha, R. A., Singh, B. K., & Yen, P. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.134 · Cited by 47 · see citing works
Shen, B., Gu, T., Shen, Z., Zhou, C., Guo, Y., Wang, J., Li, B., Xu, X., Li, F., Zhang, Q., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.08.001 · Cited by 47 · see citing works
Perspectives on youth‐onset nonalcoholic fatty liver disease
Castillo‐Leon, E., Cioffi, C. E., & Vos, M. B. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.184 · Cited by 45 · see citing works
The pathogenic oral–gut–liver axis: new understandings and clinical implications
Imai, J., Kitamoto, S., & Kamada, N. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1935877 · Cited by 45 · see citing works
Han, Y., Li, L., & Wang, B. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0960-z · Cited by 41 · see citing works
Wu, H., Chen, J., Guo, S., Deng, J., Zhou, Z., Zhang, X., Qi, T., Yu, F., & Yang, Q. L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2500099 · Cited by 41 · see citing works
Chen, L., Zhang, L., Wang, W., Qiu, W., Liu, L., Ning, A., Cao, J., Huang, M., & Zhong, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232972 · Cited by 40 · see citing works
Trust Your Gut: The Association of Gut Microbiota and Liver Disease
Manzoor, R., Ahmed, W., Afify, N., Memon, M., Yasin, M., Memon, H., Rustom, M., Akeel, M. A., & Alhajri, N. (2022) · Microorganisms · doi:10.3390/microorganisms10051045 · Cited by 40 · see citing works
Alterations of nasal microbiome in eosinophilic chronic rhinosinusitis
Liang, Y., Xie, R., Xiong, X., Hu, Z., Mao, X., Wang, X., Zhang, J., Sun, P., Yue, Z., Wang, W., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.031 · Cited by 39 · see citing works
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
Scarpellini, E., Scarcella, M., Tack, J. F., Scarlata, G. G. M., Zanetti, M., & Abenavoli, L. (2024) · Antioxidants · doi:10.3390/antiox13111386 · Cited by 39 · see citing works
Hu, Y., He, J., Zheng, P., Mao, X., Huang, Z., Yan, H., Luo, Y., Yu, J., Luo, J., Yu, B., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1955654 · Cited by 39 · see citing works
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
Kasprzak‐Drozd, K., Niziński, P., Kasprzak, P., Kondracka, A., Oniszczuk, T., Rusinek, A., & Oniszczuk, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073746 · Cited by 37 · see citing works
Zheng, Y., Hou, J., Guo, S., & Song, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01589-9 · Cited by 37 · see citing works
The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
Xiang, H., Sun, D., Liu, X., She, Z., & Chen, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.812610 · Cited by 37 · see citing works
Morán‐Ramos, S., Cerqueda‐García, D., López-Contreras, B. E., Larrieta‐Carrasco, E., Villamil‐Ramírez, H., Molina‐Cruz, S., Torres, N., Sánchez‐Tapia, M., Hernández‐Pando, R., Aguilar-Salinas, C. A., et al. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16147 · Cited by 36 · see citing works
Hoozemans, J., de Brauw, M., Nieuwdorp, M., & Gerdes, V. E. A. (2021) · Metabolites · doi:10.3390/metabo11060353 · Cited by 36 · see citing works
Guo, Q., Tang, Y., Li, Y., Xu, Z., Zhang, D., Liu, J., Wang, X., Xia, W., & Xu, S. (2021) · Nutrients · doi:10.3390/nu13072135 · Cited by 35 · see citing works
Hallmarks of the human intestinal microbiome on liver maturation and function
Almeida, J. I., Tenreiro, M. F., Martínez‐Santamaría, L., Guerrero‐Aspizua, S., Gisbert, J. P., Alves, P. M., Serra, M., & Baptista, P. M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.015 · Cited by 37 · see citing works
de Conti, A., Tryndyak, V., Willett, R. A., Borowa‐Mazgaj, B., Watson, A., Patton, R. E., Khare, S., Muskhelishvili, L., Olson, G. R., Avigan, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000194r · Cited by 32 · see citing works
Carr, R. M., Li, Y., Chau, L., Friedman, E. S., Lee, J., Adorini, L., Erickson, M., Zaru, L., Shringarpure, R., MacConell, L., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000474 · Cited by 34 · see citing works
Hu, X., Zhou, R., Li, H., Zhao, X., Sun, Y., Fan, Y., & Zhang, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.805812 · Cited by 32 · see citing works
Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease
Vittorio, J., & Lavine, J. E. (2020) · F1000Research · doi:10.12688/f1000research.24198.1 · Cited by 30 · see citing works
Self-citationZhang, Y., Jiang, W., Xu, J., Wu, N., Wang, Y., Lin, T., Liu, Y., & Liu, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.535940 · Cited by 31 · see citing works
Alemán, J. O., Henderson, W. A., Walker, J. M., Ronning, A., Jones, D. R., Walter, P. J., Daniel, S. G., Bittinger, K. L., VAUGHAN, R. D., MacArthur, R. B., et al. (2021) · Journal of Clinical and Translational Science · doi:10.1017/cts.2021.801 · Cited by 31 · see citing works
Zhao, Y., Zhao, M., Zhang, Y., Fu, Z., Jin, T., Song, J., Huang, Y., Zhao, C., & Wang, M. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117383 · Cited by 30 · see citing works
The Microbiome and Its Implications in Cancer Immunotherapy
Choudhry, H. (2021) · Molecules · doi:10.3390/molecules26010206 · Cited by 31 · see citing works
The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
Houttu, V., Boulund, U., Grefhorst, A., Soeters, M. R., Pinto‐Sietsma, S., Nieuwdorp, M., & Holleboom, A. G. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820941745 · Cited by 30 · see citing works
Mao, Q., Lin, B., Zhang, W., Zhang, Y., Zhang, Y., Cao, Q., & Xu, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1371574 · Cited by 29 · see citing works
Jia, W. P., Luo, J., Yang, F., Feng, X., Zeng, M., Dai, W., Pan, X., Yang, Y., Li, Y., Duan, Y., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2351620 · Cited by 32 · see citing works
Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children
Kordy, K., Li, F., Lee, D., Kinchen, J. M., Jew, M., Rocque, M. E. L., Zabih, S., Saavedra, M., Woodward, C. L., Cunningham, N. J., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.713234 · Cited by 29 · see citing works
Gut microbiome and nonalcoholic fatty liver disease
Wu, M., & Fan, J. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.06.006 · Cited by 30 · see citing works
Gui, Q., Jin, H., Zhu, F., Lu, H., Zhang, Q., Xu, J. M., Yang, Y., & Xiao, C. (2021) · Infectious Diseases of Poverty · doi:10.1186/s40249-021-00821-8 · Cited by 28 · see citing works
Gillard, J., & Leclercq, I. A. (2023) · Clinical Science · doi:10.1042/cs20220697 · Cited by 28 · see citing works
Updates in Metabolic Dysfunction‐Associated Fatty Liver Disease (MAFLD) in Children
Rupasinghe, K., Hind, J. M., & Hegarty, R. (2023) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003919 · Cited by 27 · see citing works
Liu, X., Liu, D., Tan, C., & Feng, W. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02402-1 · Cited by 29 · see citing works
- Authors
- Schwimmer, J. B., Johnson, J. S., Angeles, J. E., Behling, C., Belt, P. H., Borecki, I., Bross, C., Durelle, J., Goyal, N. P., Hamilton, G., Holtz, M. L., Lavine, J. E., Mitreva, M., Newton, K. P., Pan, A., Simpson, P. M., Sirlin, C. B., Sodergren, E., Tyagi, R., Yates, K. P., Weinstock, G. M., & Salzman, N. H.
- Affiliations
- University of California San Diego (US)
- The Jackson Laboratory for Genomic Medicine (US)
- Sharp Memorial Hospital (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Medical College of Wisconsin (US)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Salzman, Nita H.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 157
- Issue
- 4
- Pages
- 1109-1122
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC6756995
- OpenAlex
- W2953761756
- Cited by
- 298
- References
- 58
- Citations by year
- 2026: 31 · 2025: 37 · 2024: 41 · 2023: 54 · 2022: 32 · 2021: 56 · 2020: 40 · 2019: 6
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- School of Medicine, University of California, San Diego
- Office of Extramural Research, National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, liver fibrosis, gut microbiota, fecal microbiota, Prevotella copri, lipopolysaccharide biosynthesis, flagellar assembly, dysbiosis, alpha diversity, alanine aminotransferase, children, obesity, disease severity markers, 16S rRNA
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Bacteria, Child, Cross-Sectional Studies, DNA, Bacterial, Feces, Female, Humans, Intestines, Liver Cirrhosis, Male, Prospective Studies, RNA, Ribosomal, 16S, Severity of Illness Index, Case-Control Studies, Ribotyping, Host-Pathogen Interactions, Metagenome, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
